Chronic Inflammatory Polyradiculopathy Post-Covid-19 and the Role of Therapeutic Apheresis : A Clinical Case
Copyright by Società Italiana di Nefrologia SIN, Rome,Italy..
There is a strong correlation between SARS-CoV-2 and the onset of autoimmune neurological disease with atypical clinical presentation, characterized by limited response to medical therapy, likely caused by the underlying mechanism of the virus itself. In situations like these, after the failure of pharmacological therapy, therapeutic apheresis, including immunoadsorption, can be pursued. Treatments with IMMUSORBA TR-350 columns have proven to be particularly effective in managing refractory forms of post-Covid-19 nephropathies, leading to complete recovery of disability and elimination of neurological signs and symptoms. We discuss the case of a patient with chronic inflammatory polyradiculopathy post-Covid-19, resistant to medical therapy, effectively treated with immunoadsorption.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia - 40(2023), 3 vom: 29. Juni |
Sprache: |
Italienisch |
---|
Beteiligte Personen: |
Coviello, N [VerfasserIn] |
---|
Themen: |
Apheresis |
---|
Anmerkungen: |
Date Completed 12.07.2023 Date Revised 18.07.2023 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM359289487 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM359289487 | ||
003 | DE-627 | ||
005 | 20231226080544.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||ita c | ||
028 | 5 | 2 | |a pubmed24n1197.xml |
035 | |a (DE-627)NLM359289487 | ||
035 | |a (NLM)37427907 | ||
035 | |a (PII)2023-vol3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ita | ||
100 | 1 | |a Coviello, N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chronic Inflammatory Polyradiculopathy Post-Covid-19 and the Role of Therapeutic Apheresis |b A Clinical Case |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.07.2023 | ||
500 | |a Date Revised 18.07.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright by Società Italiana di Nefrologia SIN, Rome,Italy. | ||
520 | |a There is a strong correlation between SARS-CoV-2 and the onset of autoimmune neurological disease with atypical clinical presentation, characterized by limited response to medical therapy, likely caused by the underlying mechanism of the virus itself. In situations like these, after the failure of pharmacological therapy, therapeutic apheresis, including immunoadsorption, can be pursued. Treatments with IMMUSORBA TR-350 columns have proven to be particularly effective in managing refractory forms of post-Covid-19 nephropathies, leading to complete recovery of disability and elimination of neurological signs and symptoms. We discuss the case of a patient with chronic inflammatory polyradiculopathy post-Covid-19, resistant to medical therapy, effectively treated with immunoadsorption | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Apheresis | |
650 | 4 | |a Immunoadsorption | |
650 | 4 | |a Polyradiculopathy | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Carella, A |e verfasserin |4 aut | |
700 | 1 | |a Dell'Aquila, C |e verfasserin |4 aut | |
700 | 1 | |a Masi, G L |e verfasserin |4 aut | |
700 | 1 | |a Prisciandaro, C |e verfasserin |4 aut | |
700 | 1 | |a Tarantino, G |e verfasserin |4 aut | |
700 | 1 | |a Taurisano, M |e verfasserin |4 aut | |
700 | 1 | |a Nisi, M T |e verfasserin |4 aut | |
700 | 1 | |a Rinaldi, G |e verfasserin |4 aut | |
700 | 1 | |a D'Elia, F |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia |d 1997 |g 40(2023), 3 vom: 29. Juni |w (DE-627)NLM093699778 |x 1724-5990 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2023 |g number:3 |g day:29 |g month:06 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2023 |e 3 |b 29 |c 06 |